SAMANTHA CONSOLI: Open Payments
NPI 1487253738 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 97 payments from 17 companies in 2025. Trend: 2023 $23 · 2024 $167 · 2025 $1,765
Food & beverage: $1,680Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $358 |
| Incyte Corporation | 16 | $288 |
| ABBVIE INC. | 15 | $287 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $227 |
| Lilly USA, LLC | 7 | $129 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| UCB, Inc. | 3 | $85 |
| Biofrontera Inc. | 3 | $66 |
| LNHC, Inc | 2 | $36 |
| STRATA Skin Sciences, Inc. | 4 | $31 |
Products named: TREMFYA, OPZELURA, SKYRIZI, ILUMYA, TALTZ, Bimzelx, COSENTYX, ZELSUVMI.
Industry payments across MD — which companies pay providers there.
